Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ranjit Philip has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exercise-Induced ECG Abnormalities in Pediatric Pectus Excavatum: Evidence of Right Ventricular Compression Beyond the Haller Index

    by Karine Guerrier, Aram Bejnood, Sharvari Shyam, Rebecca Ann Hyde, Benjamin Hendrickson, Trey Eubanks, Tim Jancelewicz, Ranjit Philip

    Background: Pectus excavatum (PEX) is the most common congenital chest wall deformity and may result in cardiac compression and arrhythmias. The relationship between structural severity and exercise-induced electrocardiographic (ECG) abnormalities in pediatric patients remains unclear. Methods: We performed a retrospective study of patients aged 10–19 years that underwent standardized preoperative evaluation for PEX between 2015 and 2021, including ECG, transthoracic echocardiography (TTE), computed tomography (CT), and cardiopulmonary exercise testing (CPET). PEX severity was assessed using the Haller index (HI), while right ventricular (RV) compression was evaluated on CT. Tricuspid valve annular size (TVAS) on TTE was used as a surrogate marker of RV compression. Exercise-induced ECG abnormalities, including premature ventricular complexes (PVCs), were analyzed and correlated with HI, RV compression, and TVAS. Results: Among 124 patients (85% male; median age 15 years), 33% exhibited exercise-induced ECG abnormalities, most commonly PVCs (24% overall). PVC occurrence was not associated with Haller index severity (p = 0.35) but was significantly associated with RV compression on CT (92.6% vs. 62.1%, OR 7.64, p = 0.02). Patients with ECG abnormalities had significantly smaller TVAS compared to those without (1.98 ± 0.31 cm vs. 2.09 ± 0.33 cm, p = 0.04). Although PVCs were more frequent in patients with TVAS z-score ≤ −2.0, this did not reach statistical significance. Conclusions: Exercise-induced ventricular ectopy in pediatric PEX is associated with right ventricular compression rather than structural severity as defined by HI. Echocardiographic measures such as TVAS may serve as noninvasive markers of clinically significant compression. These findings highlight the importance of cardiac–thoracic relationships in predicting arrhythmic risk and suggest a potential for reversibility with surgical correction.

  • Open Access

    The Aortic Flow Reversal Ratio: A Quantitative Adjunct to the Bicêtre Score in Vein of Galen Malformation

    by Menachem Rimler, Ranjit Philip, Lydia Tanner, Hannah Huth, Lucas Elijovich

    Background/Objectives: The Bicêtre score for Vein of Galen Aneurysmal Malformation (VGAM) relies on existing end-organ damage. We hypothesized that transthoracic echocardiography (TTE) could quantify significant systemic steal in clinically stable neonates (Bicêtre score ≥ 12). This study evaluates the Aortic Flow Reversal Ratio (AoFRr) as a tool to measure this steal and predict treatment outcomes. Methods: In a single-center retrospective study of patients with VGAM, the AoFRr (the ratio of the diastolic reversal velocity time integral to the systolic forward volume time integral) was calculated via TTE in the abdominal aorta at the level of the diaphragm before and after endovascular embolization. Over the study period, the cohort underwent a total of 30 endovascular interventions and 49 TTEs. Pre-intervention AoFRr was correlated with the Bicêtre score, and post-intervention changes were analyzed for association with the need for subsequent embolizations. Results: In a cohort of 12 patients with a median Bicêtre score of 18, 83.3% had pre-intervention aortic diastolic flow reversal. The median pre-intervention AoFRr was 0.81, indicating substantial systemic steal despite clinical stability. A post-intervention AoFRr reduction of ≥85% was significantly associated with a lower likelihood of requiring re-intervention (p = 0.0253). Conclusions: The AoFRr quantifies substantial hemodynamic steal in VGAM patients who appear clinically stable by the Bicêtre score. Its reduction following embolization predicts a more favorable clinical course. The AoFRr is a valuable, non-invasive adjunct for risk stratification and may help optimize the timing of endovascular intervention.

  • Open Access

    Editorial: Advancing neonatal cardiology: a focus on precision medicine

    by Ranjit Philip, Mark Weems, Sandeep Chilakala

    Over the past decade, neonatal cardiology has undergone a remarkable transformation. The integration of precision medicine-anchored in genomics, advanced imaging, bioinformatics, and individualized physiology-has redefined how clinicians diagnose, prognosticate, and treat congenital and acquired cardiac conditions in the newborn period. This special issue, Advancing Neonatal Cardiology: A Focus on Precision Medicine, brings together original research and compelling case studies that exemplify this evolution-from molecular diagnosis to multimodal imaging and neurodevelopmental outcomes.The articles in this issue underscore the value of precision diagnostics across the perinatal continuum. The case report, Precise Prenatal Ultrasound Diagnosis of 22q11.2 Deletion Syndrome, highlights how systematic fetal imaging protocols can guide early genetic investigation and anticipatory management, underscoring the expanding role of fetal cardiology within multidisciplinary precision medicine teams. Similarly, the Fetal Total Anomalous Pulmonary Venous Connection: A Clinical Study of 31 Cases reflects how detailed fetal echocardiographic assessment contributes not only to early diagnosis but also to postnatal surgical planning and improved outcomes.Complementing these, the report on Neonatal Right Atrial Mass of Uncertain Etiology illustrates the diagnostic complexities encountered in the neonatal intensive care setting, where multimodal imaging and genetic insights intersect to refine clinical decisions in rare presentations.Precision medicine extends beyond anatomic diagnosis to embrace molecular and physiologic variability. The paper, The Gut Microbiota-Kawasaki Disease Axis: Emerging Evidence and Therapeutic Implications, invites us to rethink inflammation-driven cardiac conditions through a microbiome-immune-vascular lens. As the field moves toward microbiota-targeted therapies, this perspective signals a paradigm shift toward understanding the neonatal and infant cardiac milieu as part of a larger systemic ecosystem.Infants with Persistent Ductus Arteriosus demonstrates how serial echocardiographic assessment can reveal individualized cardiac trajectories, informing both timing of intervention and long-term follow-up strategies-an essential principle in neonatal precision cardiology.The intersection of cardiac physiology, placental function, and neurodevelopment is a rapidly expanding frontier. The study Placental Histology, Perioperative Brain Development, and Neurodevelopmental Outcome at One Year of Age in Patients Undergoing Neonatal Cardiac Surgery explores the placental-cardiac-cerebral axis, suggesting that precision medicine in cardiology cannot exist in isolation from fetal and neurologic sciences. Understanding how placental pathology influences postoperative brain development opens new avenues for early risk stratification and neuroprotective strategies.Rare case reports often illuminate fundamental physiologic principles. The report Electrical Alternans of the Q-T Interval and Fatal Arrhythmias Caused by Neonatal Cardiac Tumor reminds us of the vulnerability of the developing myocardium and the importance of vigilance in interpreting subtle electrocardiographic changes. At the other end of the spectrum, Time Trends in Mortality of Congenital Heart Disease in Children Aged 0-14 Years provides a macroscopic view of progress in care delivery, preventive strategies, and outcomes, emphasizing the collective success of multidisciplinary precision approaches across decades.Taken together, the studies in this issue reinforce that the future of neonatal cardiology lies in integration-of genomics with physiology, imaging with computation, and molecular insight with compassionate, individualized care. Precision medicine is not merely a technological advance; it is a framework that redefines how we understand and respond to variability among our smallest patients.As this field advances, challenges remain-equitable access to advanced diagnostics, ethical considerations in genomic screening, and the translation of data into actionable care at the bedside. Yet, the contributions in this collection offer optimism: they demonstrate how focused inquiry and collaboration continue to transform neonatal cardiology from a discipline of reactive care into one of proactive precision.

  • Open Access

    Pediatric hypertension: a toolkit for optimizing lifestyle and pharmacologic adherence

    by Aaron Walsh, Thomas Yohannan, Evan Harvey, Arif Hussain, Nirbhay Parashar, Deepank Sahni, Carmen Carroll, Ranjit Philip

    Hypertension (HTN) has significant long-term cardiovascular risks and is becoming increasingly prevalent in the pediatric population. Apart from making the diagnosis of HTN and initiating treatment, sustained adherence to lifestyle modifications is the mainstay of pediatric HTN management. Little is described regarding compliance to lifestyle recommendations as treatment for HTN despite current guidelines outlining specific dietary and physical activity recommendations that are suggested to be equated to medical prescriptions. This is possibly because there are more objective metrics such as pharmacy pick-up/refill data that can more accurately track medication compliance. The purpose of this review is to provide the general pediatrician with a standardized framework for the management of pediatric HTN with a focus on objective tools that will enable a pragmatic approach to evaluating patient compliance. Adherence to lifestyle modifications focusing on diet and physical activity may potentially impact blood pressure control beyond drug therapy compliance. Concise flowsheets and tables are provided to aid the pediatrician’s workflow in a busy clinic whilst providing essential objective data to assess patient compliance and provide nutrition and physical activity prescriptions. In this review, we outline our current understanding of lifestyle modification and medication prescription compliance trends among youths with HTN and offer real-world tools to implement in any pediatric clinic to better understand and improve patient compliance.

  • Open Access

    The Aortic Flow Reversal Ratio: A Quantitative Adjunct to the Bicêtre Score in Vein of Galen Malformation

    by Menachem Yehuda Rimler, Ranjit R Philip, Lydia Henry, Hannah Huth, Lucas Elijovich

    Objective: The Bicêtre score is a clinical tool used to guide the timing of intervention in Vein of Galen Aneurysmal Malformation (VGAM). However, it relies on the presence of end-organ damage. This study aimed to determine if an echocardiographic parameter, the Aortic Flow Reversal Ratio (AoFRr), can quantify significant systemic steal in clinically stable neonates (Bicêtre score ≥12) and to evaluate its utility in predicting treatment outcomes. Methods: We conducted a single-center retrospective study in patients with VGAM who underwent endovascular embolizations. Transthoracic echocardiography was used to calculate the AoFRr (diastolic reversal VTI / systolic forward VTI) before and after intervention. We analyzed the prevalence and degree of pre-intervention flow reversal. Linear regression was used to correlate the pre-intervention AoFRr with the Bicêtre score. The change in AoFRr post-intervention was evaluated for its association with the likelihood of requiring subsequent embolizations using Wilcoxon signed-rank and Chi-square tests. Results: In the cohort of 12 patients with a median total Bicêtre score of 18 (IQR 15.5 - 20), 83.3% demonstrated pre-intervention aortic diastolic flow reversal. The median pre-intervention AoFRr was 0.81 (IQR 0.49 - 1.05), indicating substantial systemic steal. Pre-intervention AoFRr moderately correlated with the Bicêtre score (R2 = 0.4546). The initial embolization resulted in a statistically significant mean decrease in the AoFRr of 52.80% (p = 0.0232). A post-intervention reduction in AoFRr of ≥85% was significantly associated with a lower likelihood of requiring re-intervention (p = 0.0253). Conclusion: Significant hemodynamic steal, quantified by the AoFRr, is evident on echocardiography in VGAM patients even when they are considered clinically stable by the Bicêtre score. The AoFRr provides a valuable, non-invasive measure of hemodynamic compromise that correlates with clinical severity scores. Its reduction following embolization predicts a more favorable clinical course. The AoFRr may serve as a critical adjunct to the Bicêtre score for risk stratification and for optimizing the timing of endovascular intervention.

  • A Simplified Staged Left Ventricular Recruitment Strategy to Achieve Biventricular Repair in a Neonate With Hypoplastic Left Heart Variant

    by Ranjit Philip, Jason Johnson, Ronak J. Naik, Adegbemisola A. Perkins, Shyam Sathanandam, Christopher J. Knott-Craig, Umar Boston

    Hypoplastic left heart complex presents a diverse spectrum of variants. Traditional management has been dichotomous, involving either single ventricle palliation or high-risk biventricular repair. Surgical approaches to achieve biventricular repair in children with borderline left ventricle are continually evolving. One such method is the staged left ventricular recruitment (SLVR) strategy. Here, we illustrate a unique surgical approach to SLVR, achieving biventricular repair over 22 months in a neonate with hypoplastic left heart variant.

  • Open Access

    Lessons from the Pandemic: Role of Percutaneous ECMO and Balloon Atrial Septostomy in Multi-System Inflammatory Syndrome in Children

    by Ranjit R. Philip, Claire Sentilles, Jason N. Johnson, Anthony Merlocco, Karthik Ramakrishnan, Kaitlin A. Ryan, Umar Boston, Shyam Sathanandam

    Multi-system inflammatory syndrome in children (MIS-C) in the setting of COVID-19 can be associated with severe cardiopulmonary dysfunction. This clinical deterioration may sometimes necessitate veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. We describe an algorithmic approach including the role of balloon atrial septostomy in this cohort. This is the first reported series of percutaneous VA-ECMO in pediatric patients with MIS-C for better outcomes. The lessons from this approach can be replicated in other pediatric clinical conditions and adds to the armament of multiple pediatric specialties.


  • Open Access

    Role of cardio-ankle vascular index as a predictor of left ventricular hypertrophy in the evaluation of pediatric hypertension

    by Evan Harvey, Noel Delos Santos, Bruce Alpert, Naema Zarish, Brittany Hedge, Ronak Naik, Ranjit Philip

    Aim: Cardio-ankle vascular index (CAVI) is a marker of arterial stiffness independent of blood pressure (BP) at the time of measurement. This work sought to evaluate the association of CAVI with left ventricular hypertrophy (LVH), a marker of long-standing hypertension (HTN) in the pediatric population. Methods: CAVI values from 236 children being evaluated for HTN were compared with their BP grade (normal, elevated, stage I HTN, and stage II HTN) in accordance with clinical guidelines. CAVI values were correlated to the presence of LVH and lipid profiles. One hundred seven of the studied patients had transthoracic echocardiograms available for comparison, and 126 had available lipid results. CAVI means between the groups were compared using analysis of variance. Results: There was no significant difference in CAVI values between the BP groups [median/interquartile range: normal BP (4.95/4.4–5.7), elevated BP (5.1/4.5–5.6), stage I/II HTN (5.0/4.3–5.5)]. Mean CAVI value was higher in the group that had LVH (5.53, standard deviation = 1.4 vs. 5.1, standard deviation = 1; P = 0.13) but was not statistically significant. However, higher mean CAVI value in children ≥ 15 years was significantly associated with the presence of LVH (5.9, standard deviation = 1.8 vs. 5.2 standard deviation = 0.8; P = 0.018). Conclusions: In post-pubertal children, CAVI may be a good predictor of LVH from long-standing HTN. This tool could prove useful in screening for the presence of atherosclerotic changes and provide opportunity for intervention/improved long-term outcomes.


  • Open Access

    Tricuspid Valve Annulus Size by Echocardiography: Predictor of Cardiac Limitation in Pediatric Pectus Excavatum

    by James R Chang, James R Eubanks, Timothy Jancelewicz, Vijaya M Joshi, Hugo Martinez, Samir H Shah, Elizabeth R Paton, Ranjit R Philip

    Background: The severity of pectus excavatum (PEX) as measured by Haller index (HI) does not always correlate with symptoms of aerobic capacity. Transthoracic echocardiograms (TTE) are generally reported as normal which may influence the pediatrician’s decision to refer for corrective surgery. The aim of this study was to find a reproducible TTE marker as an indicator of right ventricular compression and compare it to severity of PEX and cardiopulmonary exercise test (CPET) indices. Methods: The study included patients aged 10-19 years with an institution-based protocol for preoperative PEX evaluation with TTE, chest computed tomography (CT) for HI, and CPET from 2015-2021. We divided the patients into two groups, mild/moderate PEX (HI 2-3.5) and severe PEX (HI > 3.5). Tricuspid valve annulus size (TVAS) was compared between the groups as well as with other CPET and TTE indices using Student’s t-test. Spearman’s rank correlation coefficient was used to evaluate correlations between the severity of PEX by HI with the TTE and CPET parameters. Results: Of the 124 patients, 82 (66.1%) had severe PEX and 42 (33.9%) had mild/moderate PEX. The mean TVAS z-scores in the mild/moderate PEX group was -1.98(SD 0.51) and -2.24 (SD 0.71) in the severe PEX group (p 0.046). There was a negative correlation between the TVAS z-score and the severity of PEX but this was not statistically significant (r = -0.154, p = 0.087). There was no significant difference in peak oxygen uptake (peak V O2 ) or left ventricular ejection fraction between the severity groups. However, the TVAS z-score positively correlated with peak V O2 (median 43 ml/kg/min, r = 0.023, p = 0.01), peak V O2 percent predicted (median 86%, r = 0.19, p = 0.04), and O 2 pulse (median 12.7 ml/beat, r = 0.20, p = 0.025), and negatively correlated with V E /V CO2 (median 29, r = -0.23, p = 0.01). Conclusion: The severity of PEX by HI does not factor in the location of cardiac compression and may not always reflect the degree of cardiac limitation. The Tricuspid valve annulus size is a good TTE indicator of cardiopulmonary compromise from PEX. A TVAS z score <-2 is a good predictor of cardiac compromise in pediatric PEX. This may provide additional functional parameters in the decision-making process for corrective surgery.

  • Open Access

    Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

    by Kacie Dillon, Vineet Lamba, Ranjit R. Philip, Mark F. Weems, Ajay J. Talati

    Background: Pulmonary hypertension (PH) is a common comorbidity in infants with bronchopulmonary dysplasia (BPD). Sildenafil is a widely recognized therapy for PH, but its efficacy in infants with BPD is questionable. We propose to assess the efficacy of sildenafil in BPD-associated PH as evaluated based on transthoracic echocardiography (TTE) changes and clinical measures. Methods: Data were retrospectively and prospectively collected. Inclusion criteria were gestational age (GA) < 32 weeks, birth weight (BW) < 1500 g with severe BPD, diagnosis of PH via TTE on sildenafil treatment. PH was evaluated via TTE, which was performed monthly after 36 weeks post-menstrual age (PMA) as a standard of care, and re-reviewed by a single pediatric cardiologist, who was blind to the initial reading. Results: In total, 19 patients were enrolled in the study, having a median GA of 24 3/7 weeks (IQR 23 5/7–25 5/7) and a median BW of 598 g (IQR 572–735). Sildenafil treatment was started at a median PMA of 40.4 weeks. The median respiratory severity score (RSS) at 28 d was 6.5, RSS and FiO2 showed improvement about 12 weeks after starting sildenafil treatment. Conclusions: Improvement in PH was noted via TTE, and patients had improvement in their RSS and FiO2 after prolonged therapy. However, TTE improvements did not correlate with clinical improvements.